UB Paderborn / Katalog / Suche / in CDI

In Vitro Activity of Delafloxacin against Contemporary Bacterial Pathogens from the United States and Europe, 2014

Antimicrobial agents and chemotherapy, 2017-04, Vol.61 (4)

2017

Volltextzugriff (PDF)

In Vitro Activity of the Novel Lactone Ketolide Nafithromycin (WCK 4873) against Contemporary Clinical Bacteria from a Global Surveillance Program

Antimicrobial agents and chemotherapy, 2017-12, Vol.61 (12)

2017

Volltextzugriff (PDF)

Impact of EUCAST, CLSI and USCAST ceftaroline breakpoint changes on the susceptibility of methicillin-resistant Staphylococcus aureus isolates collected from US medical centres (2015–2018)

Clinical microbiology and infection, 2020-05, Vol.26 (5), p.658-659

2020

Volltextzugriff (PDF)

Gepotidacin (GSK2140944) In Vitro Activity against Gram-Positive and Gram-Negative Bacteria

Antimicrobial agents and chemotherapy, 2017-07, Vol.61 (7)

2017

Volltextzugriff (PDF)

Global assessment of the antimicrobial activity of polymyxin B against 54 731 clinical isolates of Gram-negative bacilli: report from the SENTRY antimicrobial surveillance programme (2001–2004)

Clinical microbiology and infection, 2006-04, Vol.12 (4), p.315-321

2006

Volltextzugriff (PDF)

In Vitro Activity of Gepotidacin (GSK2140944) against Neisseria gonorrhoeae

Antimicrobial agents and chemotherapy, 2017-03, Vol.61 (3)

2017

Volltextzugriff (PDF)

Contemporary activity of colistin and polymyxin B against a worldwide collection of Gram-negative pathogens: results from the SENTRY Antimicrobial Surveillance Program (2006-09)

Journal of antimicrobial chemotherapy, 2011-09, Vol.66 (9), p.2070-2074

2011

Volltextzugriff (PDF)

Emerging Importance of Multidrug-Resistant Acinetobacter Species and Stenotrophomonas maltophilia as Pathogens in Seriously Ill Patients: Geographic Patterns, Epidemiological Features, and Trends in the SENTRY Antimicrobial Surveillance Program (1997–1999)

Clinical infectious diseases, 2001-05, Vol.32 (Supplement-2), p.S104-S113

2001

Volltextzugriff (PDF)

Ceftolozane/tazobactam activity against drug-resistant Enterobacteriaceae and Pseudomonas aeruginosa causing healthcare-associated infections in the Asia-Pacific region (minus China, Australia and New Zealand): report from an Antimicrobial Surveillance Programme (2013–2015)

International journal of antimicrobial agents, 2018-02, Vol.51 (2), p.181-189

2018

Volltextzugriff (PDF)

Pharmacokinetic-Pharmacodynamic Evaluation of Ertapenem for Patients with Hospital-Acquired or Ventilator-Associated Bacterial Pneumonia

Antimicrobial agents and chemotherapy, 2019-06, Vol.63 (6)

2019

Volltextzugriff (PDF)

Antimicrobial susceptibility of Gram-positive bacteria isolated from European medical centres: results of the Daptomycin Surveillance Programme (2002–2004)

Clinical microbiology and infection, 2006-09, Vol.12 (9), p.844-852

2006

Volltextzugriff (PDF)

Development of Modernized Acinetobacter baumannii Susceptibility Test Interpretive Criteria for Recommended Antimicrobial Agents Using Pharmacometric Approaches

Antimicrobial agents and chemotherapy, 2023-04, Vol.67 (4), p.e0145222-e0145222

2023

Volltextzugriff (PDF)

Antimicrobial Activity of Tigecycline and Cefoperazone/Sulbactam Tested against 18,386 Gram-negative Organisms from Europe and the Asia-Pacific Region (2013–2014)

Diagnostic microbiology and infectious disease, 2017-06, Vol.88 (2), p.177-183

2017

Volltextzugriff (PDF)

Complex Clonal and Plasmid Epidemiology in the First Outbreak of Enterobacteriaceae Infection Involving VIM-1 Metallo-β-Lactamase in Spain: Toward Endemicity?

Clinical infectious diseases, 2007-11, Vol.45 (9), p.1171-1178

2007

Volltextzugriff (PDF)

Oritavancin in vitro activity against Gram-positive organisms from European medical centers: a 10-year longitudinal overview from the SENTRY Antimicrobial Surveillance Program (2010–2019)

Journal of chemotherapy (Florence), 2023-11, Vol.35 (8), p.689-699

2023

Volltextzugriff (PDF)

Antimicrobial activity of ceftobiprole and comparator agents when tested against contemporary Gram-positive and -negative organisms collected from Europe (2015)

Diagnostic microbiology and infectious disease, 2018-05, Vol.91 (1), p.77-84

2018

Volltextzugriff (PDF)

Erratum for Pfaller et al., " In Vitro Activity of Delafloxacin against Contemporary Bacterial Pathogens from the United States and Europe, 2014"

Antimicrobial agents and chemotherapy, 2018-02, Vol.62 (2)

2018

Volltextzugriff (PDF)

Oritavancin in vitro activity against gram-positive organisms from European and United States medical centers: results from the SENTRY Antimicrobial Surveillance Program for 2010–2014

Diagnostic microbiology and infectious disease, 2018-06, Vol.91 (2), p.199-204

2018

Volltextzugriff (PDF)

Bloodstream Infections Due to Candida Species: SENTRY Antimicrobial Surveillance Program in North America and Latin America, 1997-1998

Antimicrobial Agents and Chemotherapy, 2000-03, Vol.44 (3), p.747-751

2000

Volltextzugriff (PDF)

International surveillance of bloodstream infections due to Candida species: Frequency of occurrence and in vitro susceptibilities to fluconazole, ravuconazole, and voriconazole of isolates collected from 1997 through 1999 in the SENTRY antimicrobial surveillance program

Journal of clinical microbiology, 2001-09, Vol.39 (9), p.3254-3259

2001

Volltextzugriff (PDF)

Survey of Bloodstream Infections Due to Gram-Negative Bacilli: Frequency of Occurrence and Antimicrobial Susceptibility of Isolates Collected in the United States,Canada, and Latin America for the SENTRY Antimicrobial Surveillance Program, 1997

Clinical infectious diseases, 1999-09, Vol.29 (3), p.595-607

1999

Volltextzugriff (PDF)

Update of the activity of telavancin against a global collection of Staphylococcus aureus causing bacteremia, including endocarditis (2011–2014)

European journal of clinical microbiology & infectious diseases, 2017-06, Vol.36 (6), p.1013-1017

2017

Volltextzugriff (PDF)

Antimicrobial activity of the novel pleuromutilin antibiotic BC-3781 against organisms responsible for community-acquired respiratory tract infections (CARTIs)

Journal of antimicrobial chemotherapy, 2012-05, Vol.67 (5), p.1170-1175

2012

Volltextzugriff (PDF)

IMPs, VIMs and SPMs: the diversity of metallo-β-lactamases produced by carbapenem-resistant Pseudomonas aeruginosa in a Brazilian hospital

Clinical microbiology and infection, 2005-01, Vol.11 (1), p.73-76

2005

Volltextzugriff (PDF)

Metallo-β-Lactamase Gene blaIMP-15 in a Class 1 Integron, In95, from Pseudomonas aeruginosa Clinical Isolates from a Hospital in Mexico

Antimicrobial Agents and Chemotherapy, 2008-08, Vol.52 (8), p.2943-2946

2008

Volltextzugriff (PDF)

Menü

Weitere Dienste

Einstellungen

In Vitro Activity of Delafloxacin against Contemporary Bacterial Pathogens from the United States and Europe, 2014

In Vitro Activity of the Novel Lactone Ketolide Nafithromycin (WCK 4873) against Contemporary Clinical Bacteria from a Global Surveillance Program

Impact of EUCAST, CLSI and USCAST ceftaroline breakpoint changes on the susceptibility of methicillin-resistant Staphylococcus aureus isolates collected from US medical centres (2015–2018)

Gepotidacin (GSK2140944) In Vitro Activity against Gram-Positive and Gram-Negative Bacteria

Global assessment of the antimicrobial activity of polymyxin B against 54 731 clinical isolates of Gram-negative bacilli: report from the SENTRY antimicrobial surveillance programme (2001–2004)

In Vitro Activity of Gepotidacin (GSK2140944) against Neisseria gonorrhoeae

Contemporary activity of colistin and polymyxin B against a worldwide collection of Gram-negative pathogens: results from the SENTRY Antimicrobial Surveillance Program (2006-09)

Emerging Importance of Multidrug-Resistant Acinetobacter Species and Stenotrophomonas maltophilia as Pathogens in Seriously Ill Patients: Geographic Patterns, Epidemiological Features, and Trends in the SENTRY Antimicrobial Surveillance Program (1997–1999)

Ceftolozane/tazobactam activity against drug-resistant Enterobacteriaceae and Pseudomonas aeruginosa causing healthcare-associated infections in the Asia-Pacific region (minus China, Australia and New Zealand): report from an Antimicrobial Surveillance Programme (2013–2015)

Pharmacokinetic-Pharmacodynamic Evaluation of Ertapenem for Patients with Hospital-Acquired or Ventilator-Associated Bacterial Pneumonia

Antimicrobial susceptibility of Gram-positive bacteria isolated from European medical centres: results of the Daptomycin Surveillance Programme (2002–2004)

Development of Modernized Acinetobacter baumannii Susceptibility Test Interpretive Criteria for Recommended Antimicrobial Agents Using Pharmacometric Approaches

Antimicrobial Activity of Tigecycline and Cefoperazone/Sulbactam Tested against 18,386 Gram-negative Organisms from Europe and the Asia-Pacific Region (2013–2014)

Complex Clonal and Plasmid Epidemiology in the First Outbreak of Enterobacteriaceae Infection Involving VIM-1 Metallo-β-Lactamase in Spain: Toward Endemicity?

Oritavancin in vitro activity against Gram-positive organisms from European medical centers: a 10-year longitudinal overview from the SENTRY Antimicrobial Surveillance Program (2010–2019)

Antimicrobial activity of ceftobiprole and comparator agents when tested against contemporary Gram-positive and -negative organisms collected from Europe (2015)

Erratum for Pfaller et al., " In Vitro Activity of Delafloxacin against Contemporary Bacterial Pathogens from the United States and Europe, 2014"

Oritavancin in vitro activity against gram-positive organisms from European and United States medical centers: results from the SENTRY Antimicrobial Surveillance Program for 2010–2014

Bloodstream Infections Due to Candida Species: SENTRY Antimicrobial Surveillance Program in North America and Latin America, 1997-1998

International surveillance of bloodstream infections due to Candida species: Frequency of occurrence and in vitro susceptibilities to fluconazole, ravuconazole, and voriconazole of isolates collected from 1997 through 1999 in the SENTRY antimicrobial surveillance program

Survey of Bloodstream Infections Due to Gram-Negative Bacilli: Frequency of Occurrence and Antimicrobial Susceptibility of Isolates Collected in the United States,Canada, and Latin America for the SENTRY Antimicrobial Surveillance Program, 1997

Update of the activity of telavancin against a global collection of Staphylococcus aureus causing bacteremia, including endocarditis (2011–2014)

Antimicrobial activity of the novel pleuromutilin antibiotic BC-3781 against organisms responsible for community-acquired respiratory tract infections (CARTIs)

IMPs, VIMs and SPMs: the diversity of metallo-β-lactamases produced by carbapenem-resistant Pseudomonas aeruginosa in a Brazilian hospital

Metallo-β-Lactamase Gene blaIMP-15 in a Class 1 Integron, In95, from Pseudomonas aeruginosa Clinical Isolates from a Hospital in Mexico

Suchergebnisse filtern